Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Analysis of the Role of Hepatocyte SLAMF3 Receptor and Drug Resistance Proteins (MDR) in Resistance to Treatment With Sorafenib in CHC Patients

Centre Hospitalier Universitaire, Amiens · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
hepatocellular-carcinoma
hepatocyte receptor, hepatocellular carcinoma, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 901333
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.